Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 531 entries
Sorted by: Best Match Show Resources per page
Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.

Frontiers in oncology

Al-Anazi KA, Al-Jasser AM.
PMID: 25202682
Front Oncol. 2014 Aug 25;4:232. doi: 10.3389/fonc.2014.00232. eCollection 2014.

Stenotrophomonas maltophilia (S. maltophilia) is a globally emerging Gram-negative bacillus that is widely spread in environment and hospital equipment. Recently, the incidence of infections caused by this organism has increased, particularly in patients with hematological malignancy and in recipients...

Cite
Al-Anazi KA, Al-Jasser AM. Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol. 2014;4:232doi: 10.3389/fonc.2014.00232.
Al-Anazi, K. A., & Al-Jasser, A. M. (2014). Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Frontiers in oncology, 4232. https://doi.org/10.3389/fonc.2014.00232
Al-Anazi, Khalid Ahmed, and Al-Jasser, Asma M. "Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation." Frontiers in oncology vol. 4 (2014): 232. doi: https://doi.org/10.3389/fonc.2014.00232
Al-Anazi KA, Al-Jasser AM. Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol. 2014 Aug 25;4:232. doi: 10.3389/fonc.2014.00232. eCollection 2014. PMID: 25202682; PMCID: PMC4142553.
Copy Download .nbib Format: NLM
Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City.

International journal of microbiology

Nzalie RN, Gonsu HK, Koulla-Shiro S.
PMID: 27667998
Int J Microbiol. 2016;2016:3240268. doi: 10.1155/2016/3240268. Epub 2016 Sep 07.

Introduction. Community-acquired urinary tract infections (CAUTIs) are usually treated empirically. Geographical variations in etiologic agents and their antibiotic sensitivity patterns are common. Knowledge of antibiotic resistance trends is important for improving evidence-based recommendations for empirical treatment of UTIs. Our...

Cite
Nzalie RN, Gonsu HK, Koulla-Shiro S. Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City. Int J Microbiol. 2016;2016:3240268doi: 10.1155/2016/3240268.
Nzalie, R. N., Gonsu, H. K., & Koulla-Shiro, S. (2016). Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City. International journal of microbiology, 20163240268. https://doi.org/10.1155/2016/3240268
Nzalie, Rolf Nyah-Tuku, et al. "Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City." International journal of microbiology vol. 2016 (2016): 3240268. doi: https://doi.org/10.1155/2016/3240268
Nzalie RN, Gonsu HK, Koulla-Shiro S. Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City. Int J Microbiol. 2016;2016:3240268. doi: 10.1155/2016/3240268. Epub 2016 Sep 07. PMID: 27667998; PMCID: PMC5030431.
Copy Download .nbib Format: NLM
Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen.

Journal of surgical case reports

di Summa PG, Yvon A, Larcher L, Raffoul W, Koch N.
PMID: 25672974
J Surg Case Rep. 2015 Feb 10;2015(2). doi: 10.1093/jscr/rjv002.

Propionibacterium avidum is a common inhabitant of sebaceous glands, traditionally considered to be of low virulence and generally found on implanted foreign material. We report a rare case of P. avidum breast abscess, causing severe morbidity following breast reduction...

Cite
di Summa PG, Yvon A, Larcher L, et al. Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen. J Surg Case Rep. 2015;2015(2)doi: 10.1093/jscr/rjv002.
di Summa, P. G., Yvon, A., Larcher, L., Raffoul, W., & Koch, N. (2015). Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen. Journal of surgical case reports, 2015(2), . https://doi.org/10.1093/jscr/rjv002
di Summa, Pietro G, et al. "Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen." Journal of surgical case reports vol. 2015,2 (2015). doi: https://doi.org/10.1093/jscr/rjv002
di Summa PG, Yvon A, Larcher L, Raffoul W, Koch N. Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen. J Surg Case Rep. 2015 Feb 10;2015(2). doi: 10.1093/jscr/rjv002. PMID: 25672974; PMCID: PMC4323737.
Copy Download .nbib Format: NLM
Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital, Northern Ethiopia.

SpringerPlus

Wasihun AG, Wlekidan LN, Gebremariam SA, Dejene TA, Welderufael AL, Haile TD, Muthupandian S.
PMID: 26155453
Springerplus. 2015 Jul 03;4:314. doi: 10.1186/s40064-015-1056-x. eCollection 2015.

Bacterial bloodstream infections are a major public health problem, which leads to high morbidity and mortality of patients. On time diagnosis and appropriate medication will be the best way to save the lives of affected ones. The aim of...

Cite
Wasihun AG, Wlekidan LN, Gebremariam SA, et al. Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital, Northern Ethiopia. Springerplus. 2015;4:314doi: 10.1186/s40064-015-1056-x.
Wasihun, A. G., Wlekidan, L. N., Gebremariam, S. A., Dejene, T. A., Welderufael, A. L., Haile, T. D., & Muthupandian, S. (2015). Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital, Northern Ethiopia. SpringerPlus, 4314. https://doi.org/10.1186/s40064-015-1056-x
Wasihun, Araya Gebreyesus, et al. "Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital, Northern Ethiopia." SpringerPlus vol. 4 (2015): 314. doi: https://doi.org/10.1186/s40064-015-1056-x
Wasihun AG, Wlekidan LN, Gebremariam SA, Dejene TA, Welderufael AL, Haile TD, Muthupandian S. Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital, Northern Ethiopia. Springerplus. 2015 Jul 03;4:314. doi: 10.1186/s40064-015-1056-x. eCollection 2015. PMID: 26155453; PMCID: PMC4489972.
Copy Download .nbib Format: NLM
Editorial on two chronic low back pain studies: A major change in surgical management of disc disease?.

Surgical neurology international

Pawl R.
PMID: 24340235
Surg Neurol Int. 2013 Oct 29;4:S373-4. doi: 10.4103/2152-7806.120780. eCollection 2013.

In two recent publications, the authors' hypothesis was that Modic type 1 changes seen in patients with chronic low back pain and herniated lumbar discs may be attributed to bacterial infection/inflammation. The first study showed that many herniated discs...

Cite
Pawl R. Editorial on two chronic low back pain studies: A major change in surgical management of disc disease?. Surg Neurol Int. 2013;4:S373-4doi: 10.4103/2152-7806.120780.
Pawl, R. (2013). Editorial on two chronic low back pain studies: A major change in surgical management of disc disease?. Surgical neurology international, 4S373-4. https://doi.org/10.4103/2152-7806.120780
Pawl, Ron. "Editorial on two chronic low back pain studies: A major change in surgical management of disc disease?." Surgical neurology international vol. 4 (2013): S373-4. doi: https://doi.org/10.4103/2152-7806.120780
Pawl R. Editorial on two chronic low back pain studies: A major change in surgical management of disc disease?. Surg Neurol Int. 2013 Oct 29;4:S373-4. doi: 10.4103/2152-7806.120780. eCollection 2013. PMID: 24340235; PMCID: PMC3841939.
Copy Download .nbib Format: NLM
Congenital broncho-oesophageal fistula: An unusual cause of persistent pneumonia in a young adult.

Respiratory medicine case reports

Savvoula S, Vasiliki P, Kyparisia K, Christina A, Ioannis M, Athanasios K.
PMID: 26029609
Respir Med Case Rep. 2013 Jan 12;8:21-4. doi: 10.1016/j.rmcr.2012.12.003. eCollection 2013.

A 19-year-old female with a 3-day history of high temperature, productive cough and dyspnoea was admitted due to diabetic ketoacidosis and pneumonia of the right lower lobe. Antibiotics (amoxicillin-clavulanic acid), insulin, fluids and electrolytes were administered, as appropriate. The...

Cite
Savvoula S, Vasiliki P, Kyparisia K, et al. Congenital broncho-oesophageal fistula: An unusual cause of persistent pneumonia in a young adult. Respir Med Case Rep. 2013;8:21-4doi: 10.1016/j.rmcr.2012.12.003.
Savvoula, S., Vasiliki, P., Kyparisia, K., Christina, A., Ioannis, M., & Athanasios, K. (2013). Congenital broncho-oesophageal fistula: An unusual cause of persistent pneumonia in a young adult. Respiratory medicine case reports, 821-4. https://doi.org/10.1016/j.rmcr.2012.12.003
Savvoula, Savvidou, et al. "Congenital broncho-oesophageal fistula: An unusual cause of persistent pneumonia in a young adult." Respiratory medicine case reports vol. 8 (2013): 21-4. doi: https://doi.org/10.1016/j.rmcr.2012.12.003
Savvoula S, Vasiliki P, Kyparisia K, Christina A, Ioannis M, Athanasios K. Congenital broncho-oesophageal fistula: An unusual cause of persistent pneumonia in a young adult. Respir Med Case Rep. 2013 Jan 12;8:21-4. doi: 10.1016/j.rmcr.2012.12.003. eCollection 2013. PMID: 26029609; PMCID: PMC3920443.
Copy Download .nbib Format: NLM
Pharmacists' knowledge of the safety of antibiotics for systemic use.

The International journal of risk & safety in medicine

Yakimova Y.
PMID: 26639686
Int J Risk Saf Med. 2015;27:S11-2. doi: 10.3233/JRS-150670.

BACKGROUND: Patients decide to take antibiotics themselves in 21% of cases of acute respiratory viral infections, influenza and acute respiratory infections [1]. The main factor of drug purchase at a pharmacy is pharmacist's recommendation. In 14% of cases of...

Cite
Yakimova Y. Pharmacists' knowledge of the safety of antibiotics for systemic use. Int J Risk Saf Med. 2015;27:S11-2doi: 10.3233/JRS-150670.
Yakimova, Y. (2015). Pharmacists' knowledge of the safety of antibiotics for systemic use. The International journal of risk & safety in medicine, 27S11-2. https://doi.org/10.3233/JRS-150670
Yakimova, Y. "Pharmacists' knowledge of the safety of antibiotics for systemic use." The International journal of risk & safety in medicine vol. 27 (2015): S11-2. doi: https://doi.org/10.3233/JRS-150670
Yakimova Y. Pharmacists' knowledge of the safety of antibiotics for systemic use. Int J Risk Saf Med. 2015;27:S11-2. doi: 10.3233/JRS-150670. PMID: 26639686.
Copy Download .nbib Format: NLM
Ab Initio Raman Spectra of β-Lactamase Inhibitor Intermediates Bound to E166A SHV β-Lactamase.

Journal of chemical theory and computation

Miani A, Helfand MS, Raugei S.
PMID: 26613155
J Chem Theory Comput. 2009 Aug 11;5(8):2158-72. doi: 10.1021/ct900131q.

The assignment and the analysis of the experimental vibrational Raman spectra of enzyme bound β-lactamase inhibitors may be of help to understand the mechanisms responsible for bacterial drug resistance. We present a computational study of the structural and vibrational...

Cite
Miani A, Helfand MS, Raugei S. Ab Initio Raman Spectra of β-Lactamase Inhibitor Intermediates Bound to E166A SHV β-Lactamase. J Chem Theory Comput. 2009;5(8):2158-72doi: 10.1021/ct900131q.
Miani, A., Helfand, M. S., & Raugei, S. (2009). Ab Initio Raman Spectra of β-Lactamase Inhibitor Intermediates Bound to E166A SHV β-Lactamase. Journal of chemical theory and computation, 5(8), 2158-72. https://doi.org/10.1021/ct900131q
Miani, Andrea, et al. "Ab Initio Raman Spectra of β-Lactamase Inhibitor Intermediates Bound to E166A SHV β-Lactamase." Journal of chemical theory and computation vol. 5,8 (2009): 2158-72. doi: https://doi.org/10.1021/ct900131q
Miani A, Helfand MS, Raugei S. Ab Initio Raman Spectra of β-Lactamase Inhibitor Intermediates Bound to E166A SHV β-Lactamase. J Chem Theory Comput. 2009 Aug 11;5(8):2158-72. doi: 10.1021/ct900131q. PMID: 26613155.
Copy Download .nbib Format: NLM
Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014).

Turkish journal of urology

Yılmaz N, Ağuş N, Bayram A, Şamlıoğlu P, Şirin MC, Derici YK, Hancı SY.
PMID: 27011879
Turk J Urol. 2016 Mar;42(1):32-6. doi: 10.5152/tud.2016.90836.

OBJECTIVE: Urinary tract infections (UTIs) are among the most frequently seen community-acquired infections worldwide. E. coli causes 90% of urinary system infections. To guide the empirical therapy, the resistance pattern of E. coli responsible for community-acquired UTI was evaluated...

Cite
Yılmaz N, Ağuş N, Bayram A, et al. Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turk J Urol. 2016;42(1):32-6doi: 10.5152/tud.2016.90836.
Yılmaz, N., Ağuş, N., Bayram, A., Şamlıoğlu, P., Şirin, M. C., Derici, Y. K., & Hancı, S. Y. (2016). Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turkish journal of urology, 42(1), 32-6. https://doi.org/10.5152/tud.2016.90836
Yılmaz, Nisel, et al. "Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014)." Turkish journal of urology vol. 42,1 (2016): 32-6. doi: https://doi.org/10.5152/tud.2016.90836
Yılmaz N, Ağuş N, Bayram A, Şamlıoğlu P, Şirin MC, Derici YK, Hancı SY. Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turk J Urol. 2016 Mar;42(1):32-6. doi: 10.5152/tud.2016.90836. PMID: 27011879; PMCID: PMC4791079.
Copy Download .nbib Format: NLM
Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Open forum infectious diseases

Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC.
PMID: 26509182
Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep.

Background.  Antibiotic use predisposes patients to Clostridium difficile infections (CDI), and approximately 32% of these infections are community-associated (CA) CDI. The population-level impact of antibiotic use on adult CA-CDI rates is not well described. Methods.  We used 2011 active...

Cite
Dantes R, Mu Y, Hicks LA, et al. Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open Forum Infect Dis. 2015;2(3):ofv113doi: 10.1093/ofid/ofv113.
Dantes, R., Mu, Y., Hicks, L. A., Cohen, J., Bamberg, W., Beldavs, Z. G., Dumyati, G., Farley, M. M., Holzbauer, S., Meek, J., Phipps, E., Wilson, L., Winston, L. G., McDonald, L. C., & Lessa, F. C. (2015). Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open forum infectious diseases, 2(3), ofv113. https://doi.org/10.1093/ofid/ofv113
Dantes, Raymund, et al. "Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection." Open forum infectious diseases vol. 2,3 (2015): ofv113. doi: https://doi.org/10.1093/ofid/ofv113
Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC. Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep. PMID: 26509182; PMCID: PMC4551478.
Copy Download .nbib Format: NLM
Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?.

Pharmacognosy reviews

Cheesman MJ, Ilanko A, Blonk B, Cock IE.
PMID: 28989242
Pharmacogn Rev. 2017 Jul-Dec;11(22):57-72. doi: 10.4103/phrev.phrev_21_17.

The discovery of penicillin nearly 90 years ago revolutionized the treatment of bacterial disease. Since that time, numerous other antibiotics have been discovered from bacteria and fungi, or developed by chemical synthesis and have become effective chemotherapeutic options. However,...

Cite
Cheesman MJ, Ilanko A, Blonk B, et al. Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?. Pharmacogn Rev. 2017;11(22):57-72doi: 10.4103/phrev.phrev_21_17.
Cheesman, M. J., Ilanko, A., Blonk, B., & Cock, I. E. (2017). Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?. Pharmacognosy reviews, 11(22), 57-72. https://doi.org/10.4103/phrev.phrev_21_17
Cheesman, Matthew J, et al. "Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?." Pharmacognosy reviews vol. 11,22 (2017): 57-72. doi: https://doi.org/10.4103/phrev.phrev_21_17
Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?. Pharmacogn Rev. 2017 Jul-Dec;11(22):57-72. doi: 10.4103/phrev.phrev_21_17. PMID: 28989242; PMCID: PMC5628525.
Copy Download .nbib Format: NLM
Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition.

ACS infectious diseases

King DT, King AM, Lal SM, Wright GD, Strynadka NC.
PMID: 27622530
ACS Infect Dis. 2015 Apr 10;1(4):175-84. doi: 10.1021/acsinfecdis.5b00007. Epub 2015 Feb 11.

Emerging β-lactamase-mediated resistance is threatening the clinical utility of the single most prominent class of antibacterial agents used in medicine, the β-lactams. The diazabicyclooctane avibactam is able to inhibit a wider range of serine β-lactamases than has been previously...

Cite
King DT, King AM, Lal SM, et al. Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition. ACS Infect Dis. 2015;1(4):175-84doi: 10.1021/acsinfecdis.5b00007.
King, D. T., King, A. M., Lal, S. M., Wright, G. D., & Strynadka, N. C. (2015). Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition. ACS infectious diseases, 1(4), 175-84. https://doi.org/10.1021/acsinfecdis.5b00007
King, Dustin T, et al. "Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition." ACS infectious diseases vol. 1,4 (2015): 175-84. doi: https://doi.org/10.1021/acsinfecdis.5b00007
King DT, King AM, Lal SM, Wright GD, Strynadka NC. Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition. ACS Infect Dis. 2015 Apr 10;1(4):175-84. doi: 10.1021/acsinfecdis.5b00007. Epub 2015 Feb 11. PMID: 27622530.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 531 entries